129 related articles for article (PubMed ID: 3164635)
1. Acquired homozygosity of the rearranged bcr allele during the acute leukemic phase of a patient with Ph-negative chronic myeloid leukemia.
Reeve AE; Morris CM; Fitzgerald PH
Blood; 1988 Jul; 72(1):24-8. PubMed ID: 3164635
[TBL] [Abstract][Full Text] [Related]
2. Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.
Bartram CR; Janssen JW; Becher R; de Klein A; Grosveld G
J Exp Med; 1986 Nov; 164(5):1389-96. PubMed ID: 3464689
[TBL] [Abstract][Full Text] [Related]
3. Transposition of c-abl oncogene in a case of masked Ph chromosome duplicated in blastic phase.
Maserati E; Cavalli P; Casalone R; Morandi S; Pasquali F
Hum Genet; 1988 Mar; 78(3):248-50. PubMed ID: 3162225
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis.
Andrews DF; Collins SJ
Leukemia; 1987 Oct; 1(10):718-24. PubMed ID: 3312834
[TBL] [Abstract][Full Text] [Related]
5. Molecular characteristics of chronic myelogenous leukemia in blast crisis.
Blick M; Romero P; Talpaz M; Kurzrock R; Shtalrid M; Andersson B; Trujillo J; Beran M; Gutterman J
Cancer Genet Cytogenet; 1987 Aug; 27(2):349-56. PubMed ID: 3474057
[TBL] [Abstract][Full Text] [Related]
6. Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis.
Collins SJ; Groudine MT
Blood; 1987 Mar; 69(3):893-8. PubMed ID: 3545323
[TBL] [Abstract][Full Text] [Related]
7. Persistence of CML despite deletion of rearranged bcr/c-abl sequences.
Bartram CR; Janssen JW; Becher R
Haematol Blood Transfus; 1987; 31():145-8. PubMed ID: 3481749
[No Abstract] [Full Text] [Related]
8. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
9. [Molecular genetics of the pathogenesis and classification of chronic myelocytic leukemia].
Bartram CR
Onkologie; 1987 Jun; 10(3):127-32. PubMed ID: 3306531
[TBL] [Abstract][Full Text] [Related]
10. The variable hematologic expression of the BCR-ABL genomic mutation and its possible determinants.
Fitzgerald PH; Morris CM
Cancer Genet Cytogenet; 1989 Oct; 42(1):9-25. PubMed ID: 2790750
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia.
Kurzrock R; Kloetzer WS; Talpaz M; Blick M; Walters R; Arlinghaus RB; Gutterman JU
Blood; 1987 Jul; 70(1):233-6. PubMed ID: 2885048
[TBL] [Abstract][Full Text] [Related]
12. The genomic breakpoint in a patient with Philadelphia-positive acute leukemia is 5' of the breakpoint cluster region.
Rassool F; Foroni L; Rahemtulla A; Dreazen O; Wiedemann L; Guo AP; Legon S; Catovsky D; Luzzatto L; Goldman J
Cancer Genet Cytogenet; 1988 Jun; 32(2):217-27. PubMed ID: 3259155
[TBL] [Abstract][Full Text] [Related]
13. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
Collins SJ
J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the bcr rearrangement in a case of Ph'-negative blastic crisis of Ph'-positive chronic myelogenous leukemia.
Melani C; Canepa L; Sessarego M; Miglino M; Ferraris AM; Gaetani GF
Eur J Haematol; 1989 Jan; 42(1):32-7. PubMed ID: 2914593
[TBL] [Abstract][Full Text] [Related]
15. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
16. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal in situ hybridization and Southern blot analyses using c-abl, c-sis, or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations.
Abe S; Minamihisamatsu M; Ishihara T; Sasaki M
Cancer Genet Cytogenet; 1989 Mar; 38(1):61-74. PubMed ID: 2713815
[TBL] [Abstract][Full Text] [Related]
18. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K
Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493
[TBL] [Abstract][Full Text] [Related]
19. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia.
Hagemeijer A; Buijs A; Smit E; Janssen B; Creemers GJ; Van der Plas D; Grosveld G
Genes Chromosomes Cancer; 1993 Dec; 8(4):237-45. PubMed ID: 7512367
[TBL] [Abstract][Full Text] [Related]
20. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
